RCGP slates DoH bid to use appraisal against practices
By Tom Ireland, 19 April 2010
The RCGP has criticised DoH guidance instructing PCTs to use evidence from appraisal against poor practices.
Prof Pringle: appraisal not designed to improve practice performance
Professor Mike Pringle, RCGP medical director for revalidation, said the department should never confuse appraisal of doctors with performance management of practices.
Last week GP newspaper revealed DoH guidance instructing PCTs how best to terminate GMS contracts where practices are underperforming.
As well as scrutinising GP contract clauses and performers list rules, it recommends that ‘evidence of poor performance be built up from a variety of sources such as complaints, appraisal and reviews'.
But Professor Pringle said appraisal was not designed to improve the performance of practices.
‘Revalidation will improve an individual's quality through reflection and learning and can reveal performance issues locally or nationally.
‘But discussing practice performance is not the right avenue for evidence taken through appraisal,' he said.
The DoH guidance Raising The Bar recommended PCTs call upon relevant experts, such as health and safety experts, to scrutinise practices' adherence to key contractual clauses.
The document said ‘it is essential to take an aggressive approach'.
Quick links
Additional Information

Latest jobs Jobs web feed
- Salaried GP The Practice plc £75-85k FTE +NHS pension, Ely or Leicester
- Regional Clinical Leads The Practice plc Salary £95-105k FTE + NHS pension, Leicester or Sheffield
- dr-locums are currently recruiting locum GP's in the East of England who are interested in Out Of Hours work. dr-locums Earn up to £1,000.00 a day, East Anglia
- Locum GP's in Luton. dr-locums £70.00ph - £105.00ph, Luton
- Locum GP's in Hertfordshire dr-locums £70.00ph - £105.00ph, Hertfordshire
- Locums GP Wolverhampton Pegasus Medical £70 per hour, Wolverhampton and West Midlands long term
Most read
Most commented
MIMS Drug Search
Possible searches include drugs (by brand, generic ingredient or drug class), diseases and more.







